Home » Topics » Regulatory

Regulatory
RSS

Eisai obtains FDA approval for new formulation of AcipHex

April 2, 2013

FDA approves Biogen Idec's Tecfidera as first-line oral treatment for MS

March 28, 2013

FDA approves botulism antitoxin manufactured by Cangene

March 27, 2013

Chugai gains Japanese approval for subcutaneous formulation of Actemra

March 27, 2013

Shionogi receives approval for metreleptin in Japan

March 27, 2013

Acofide tablets approved in Japan for functional dyspepsia

March 27, 2013

FDA approves Navidea's imaging drug Lymphoseek

March 14, 2013

U.K. approval for Duexis for osteoarthritis, rheumatoid arthritis and ankylosing spondylitis

March 8, 2013

Lundbeck's Selincro approved in E.U. for alcohol dependence

March 1, 2013

European Commission approves Ilaris in acute gouty arthritis indication

March 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...